Product Details for: Omlyclo
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
75MG/0.5ML
Pre-Filled Syringe
351(k) Interchangeable
Omlyclo
Rx
002
Injection
Subcutaneous
150MG/ML
Pre-Filled Syringe
351(k) Interchangeable
Omlyclo
Rx
003
Injection
Subcutaneous
300MG/2ML (150MG/ML)
Pre-Filled Syringe
351(k) Interchangeable
Omlyclo
Rx
Proper Name
omalizumab-igec
omalizumab-igec
Reference Product Proper Name
omalizumab
omalizumab
Reference Product Properietary Name
Xolair
Xolair
BLA Number
761399
761399
Applicant
CELLTRION, Inc.
CELLTRION, Inc.
Original Approval Date
March 7, 2025
March 7, 2025
Date of First Licensure